Urology · Durango, CO
NPI
1891057923
Since 2012
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1010 Three Springs Blvd Ste 270
Durango, CO, 81301
Phone (970) 764-3845
Groups this clinician bills Medicare through
Medicare paid, 2024
$348K
5,945 services
Medicare patients, 2024
285
Average age 72
Drug cost, 2024
$129K
1,186 prescriptions
Company payments, 2025
$73K
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James A McBride was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 258 times for 188 patients. In total James A McBride billed 5,945 services in 86 codes, and Medicare paid $348K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-15.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 258 | 188 | $11.68 | $3,015 |
| 87798 Infectious Agent Detection by DNA/RNA | Office | 221 | 17 | $34.39 | $7,600 |
| 99214 Office E&M - Established | Office | 192 | 139 | $88.86 | $17K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 106 | 26 | $49.58 | $5,256 |
| 87481 Infectious Agent Detection by DNA/RNA | Office | 68 | 17 | $34.39 | $2,338 |
| 99204 Office E&M - New | Office | 56 | 56 | $111.05 | $6,219 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 44 | 20 | $38.43 | $1,691 |
| 99215 Office E&M - Established | Office | 43 | 39 | $122.64 | $5,273 |
| 52000 Cystourethroscopy | Facility | 38 | 31 | $53.24 | $2,023 |
| 51798 Ultrasound - Nonspecific | Office | 33 | 33 | $8.99 | $297 |
| 54405 Other Organ Systems | Facility | 29 | 29 | $616.17 | $18K |
| 54235 Other Organ Systems | Facility | 29 | 29 | $29.14 | $845 |
| 81003 Clinical Chemistry | Office | 25 | 25 | $2.13 | $53.19 |
| 87640 Infectious Agent Detection by DNA/RNA | Office | 17 | 17 | $34.39 | $585 |
| 52000 Cystourethroscopy | Office | 17 | 16 | $191.77 | $3,260 |
By year: 2022 $423K for 5,790 services; 2023 $194K for 4,304 services; 2024 $348K for 5,945 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87798 Infectious Agent Detection by DNA/RNA | 221 | 17 | $34.39 | $7,600 |
| 87481 Infectious Agent Detection by DNA/RNA | 68 | 17 | $34.39 | $2,338 |
| 81003 Clinical Chemistry | 25 | 25 | $2.13 | $53.19 |
| 87653 Infectious Agent Detection by DNA/RNA | 17 | 17 | $34.39 | $585 |
| 87640 Infectious Agent Detection by DNA/RNA | 17 | 17 | $34.39 | $585 |
| 87556 Infectious Agent Detection by DNA/RNA | 17 | 17 | $40.85 | $694 |
| 87651 Infectious Agent Detection by DNA/RNA | 17 | 17 | $34.39 | $585 |
Medicare prescription drug claims, 2024
In 2024, the drug James A McBride prescribed most often to Medicare patients was Testosterone Cypionate, with 293 prescriptions and refills. In total James A McBride wrote 1,186 Medicare prescriptions that cost $129K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Testosterone Cypionate Generic | 293 | 455 | 115 | $17K |
| Anastrozole Generic | 148 | 363 | 55 | $914 |
| Tamsulosin Hcl Generic | 128 | 330 | 56 | $1,641 |
| Celecoxib Generic | 64 | 68 | 53 | $1,472 |
| Tramadol Hcl Generic | 54 | 54 | 53 | $92.31 |
| Finasteride Generic | 49 | 145 | 19 | $629 |
| Myrbetriq Mirabegron | 48 | 88 | 12 | $39K |
| Testosterone Generic | 35 | 43 | 12 | $8,692 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 33 | 33 | 30 | $405 |
| Ciprofloxacin Hcl Generic | 32 | 32 | 31 | $186 |
| Gabapentin Generic | 28 | 28 | 25 | $48.41 |
| Tadalafil Generic | 25 | 47 | Under 11 | $523 |
| Cabergoline Generic | 20 | 30 | Under 11 | $1,477 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 19 | 27 | 18 | $116 |
| Gemtesa Vibegron | 19 | 50 | Under 11 | $24K |
Brand drugs: 102 claims; generic drugs: 1,067 claims; opioid claims: 62.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James A McBride $73K ($73K in general payments such as food, travel and fees) from 23 companies. The largest payer was Boston Scientific Corporation with $58K.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 65 | $58K |
| Endo USA, Inc. | 19 | $15K |
| Antares Pharma, Inc. | 11 | $172 |
| Janssen Biotech, Inc. JNJ | 5 | $114 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $104 |
| Ferring Pharmaceuticals Inc. | 4 | $90.38 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $89 |
| Sumitomo Pharma America, Inc. 4506.T | 3 | $61.76 |
| Astellas Pharma US Inc 4503.T | 2 | $46.41 |
| Progenics Pharmaceuticals, Inc. | 2 | $45.7 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.